CLAZF OTC
Claritas Pharmaceuticals, Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: -99.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$10M
-58.6% ▼
5Y CAGR: +74.7%
Total Liabilities
$9M
-68.8% ▼
5Y CAGR: +113.8%
Shareholders Equity
$2M
+143.8% ▲
5Y CAGR: +27.9%
Cash & Investments
$5K
-84.4% ▼
5Y CAGR: -61.9%
Total Debt
$925K
+25.7% ▲
Net Debt
$920K
+30.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $673K | $4M | $227K | $32K | $5K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $673K | $4M | $227K | $32K | $5K |
| Net Receivables | $0 | $113K | $520K | $121K | $206K |
| Inventory | -$4M | -$113 | -$520 | -$121 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $5M | $4M | $747K | $153K | $975K |
| Property, Plant & Equip. | $0 | $0 | $0 | $0 | $0 |
| Goodwill & Intangibles | $0 | $61M | $59M | $25M | $9M |
| Long-Term Investments | $0 | $0 | $0 | $8K | $6K |
| Other Non-Current Assets | $0 | -$0 | $0 | $0 | $0 |
| Total Non-Current Assets | $0 | $61M | $59M | $25M | $9M |
| Total Assets | $5M | $65M | $60M | $25M | $10M |
| — Liabilities — | |||||
| Accounts Payable | $1M | $582K | $2M | $2M | $908K |
| Short-Term Debt | $0 | $0 | $246K | $363K | $925K |
| Deferred Revenue | $0 | $0 | -$2M | -$2M | -$908K |
| Other Current Liabilities | $0 | $0 | $0 | $483K | $667K |
| Total Current Liabilities | $2M | $4M | $8M | $6M | $7M |
| Long-Term Debt | $0 | $3M | $0 | $373K | $0 |
| Other Non-Current Liab. | $0 | $53M | $31M | $13M | $40K |
| Total Non-Current Liabilities | $0 | $73M | $42M | $23M | $2M |
| Total Liabilities | $2M | $77M | $50M | $29M | $9M |
| — Equity — | |||||
| Common Stock | $0 | $29M | $44M | $0 | $57M |
| Retained Earnings | -$13M | -$45M | -$38M | -$59M | -$55M |
| Accumulated OCI | $16M | $33M | $48M | $0 | $0 |
| Total Stockholders Equity | $3M | -$12M | $10M | -$3M | $2M |
| Total Liabilities & Equity | $5M | $65M | $60M | $25M | $10M |
| — Key Metrics — | |||||
| Total Debt | $0 | $3M | $246K | $736K | $925K |
| Net Debt | -$673K | -$818K | $19K | $704K | $920K |
| Total Investments | $0 | $0 | $0 | $8K | $6K |